Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
164.66 USD
0.25%
Market Closed
Updated:
Apr 19, 2024
Abbvie Inc
Deferred Income Tax
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbvie Inc
Deferred Income Tax Peer Comparison
Comparables:
GILD
AMGN
VRTX
REGN
SGEN
Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
Deferred Income Tax
$2B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Deferred Income Tax
$1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
34%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Deferred Income Tax
$2.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
22%
|
CAGR 10-Years
-4%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Seagen Inc
NASDAQ:SGEN
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Deferred Income Tax?
Deferred Income Tax
2B
USD
2B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Deferred Income Tax amounts to 2B USD.
What is Abbvie Inc's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
13%
13%
Over the last year, the Deferred Income Tax growth was -11%. The average annual Deferred Income Tax growth rates for Abbvie Inc have been -19% over the past three years , 13% over the past five years .
You don't have any saved screeners yet
